Profile data from OpenSecrets reveals that Otsuka Pharmaceutical contributed $293,606 and spent $1,650,000 on lobbying in 2024, with a significant share of its lobbyists being former government officials. This revolving door practice raises concerns regarding potential conflicts of interest and undue corporate influence on policymaking.

Otsuka Pharmaceutical released its Economic and Health Impact Report 2023/2024 detailing its contributions to the US economy, including support for over 10,520 jobs, generation of over $1.2 billion in labor income, and $2.7 billion in economic output. The report also highlights the company's inclusive clinical research efforts and collaboration with patient advocacy groups.

Otsuka Pharmaceutical released its 2023/2024 Economic and Health Impact Report detailing its significant contributions to the US economy through direct support of 10,520 jobs, over $1.2 billion in labor income, $2.7 billion in economic output, and a focus on promoting diversity in clinical research to ensure equitable healthcare access.

Otsuka Pharmaceutical spent $1,500,000 on federal lobbying efforts in 2023, as reported by OpenSecrets. This lobbying expenditure is viewed as a corporate attempt to influence U.S. policy, raising concerns about democratic accountability and corporate influence over political processes.

Otsuka Pharmaceutical Co., Ltd. spent $1,500,000 on lobbying activities in 2023, as reported by OpenSecrets. The report details the lobbyists hired by the company and highlights its political spending.

Otsuka Group approved a comprehensive Human Rights Policy on December 22, 2020, reaffirming its commitment to international human rights standards, labor rights, and ethical business practices. The policy outlines adherence to frameworks such as the UN Guiding Principles on Business and Human Rights, and details mechanisms for human rights due diligence, stakeholder dialogue, and remedial actions in cases of adverse impacts.